300497 Jiangxi Fushine Pharmaceutical
- 10.00
- -0.14-1.38%
Jiangxi Fushine Pharmaceutical News
Jiangxi Fushine Pharmaceutical: Announcement on the signing of the “Agreement on Termination of Special Shareholders' Rights”
Jiangxi Fushine Pharmaceutical: Announcement of Resolutions of the 21st Meeting of the Fourth Board of Directors
Jiangxi Fushine Pharmaceutical: Notice on the holding subsidiary completing the registration of industrial and commercial changes and issuing a business license
Jiangxi Fushine Pharmaceutical: Announcement on the progress of the company's provision of guarantees to wholly-owned subsidiaries
Jiangxi Fushine Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Jiangxi Fushine Pharmaceutical: Legal Opinion of Beijing Zhonglun Law Firm on the 2023 Annual General Meeting of Shareholders of Jiangxi Fuxiang Pharmaceutical Co., Ltd.
Jiangxi Fushine Pharmaceutical: 300497 Fuxiang Pharmaceutical Investor Relations Management Information 20240516
Jiangxi Fushine Pharmaceutical: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Jiangxi
Jiangxi Fushine Pharmaceutical: 300497 Fuxiang Pharmaceutical Investor Relations Management Information 20240509
Jiangxi Fushine Pharmaceutical: Announcement on the progress of the plan for the controlling shareholders, actual controllers, chairman, vice chairman and senior management of the company to increase their shareholding in the company and more than half of the time
Jiangxi Fushine Pharmaceutical: Announcement on the completion of the increase in holdings of the controlling shareholders, actual controllers and chairman of the company
Jiangxi Fushine Pharmaceutical: Announcement on Wholly-owned Subsidiaries Passing Pharmaceutical GMP Compliance Checks
Jiangxi Fushine Pharmaceutical: Announcement on preparation for impairment of long-term equity investments in subsidiaries
Jiangxi Fushine Pharmaceutical: Resolutions of the First Special Meeting of Independent Directors of the Fourth Board of Directors
Jiangxi Fushine Pharmaceutical: Notice on using part of idle own funds for cash management
Jiangxi Fushine Pharmaceutical: Amendments to the Articles of Association (April 2024)
Jiangxi Fushine Pharmaceutical: Report on the work of the Board of Supervisors for the year 2023
Jiangxi Fushine Pharmaceutical: Announcement on the expected daily related transactions of the company in 2024
Jiangxi Fushine Pharmaceutical: Verification Report on the 2023 Fuxiang Pharmaceutical Revenue Deduction Status Table
Jiangxi Fushine Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Analysis
Price Target
No Data
